Paul Mitchell And NotAnalyse

List of bibliographic references

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
001597	Paul Mitchell [Australie] ; Francesco Bandello [Italie] ; Ursula Schmidt-Erfurth [Autriche] ; Gabriele E. Lang [Allemagne] ; Pascal Massin [France] ; Reinier O. Schlingemann [Pays-Bas] ; Florian Sutter [Suisse] ; Christian Simader [Autriche] ; Gabriela Burian [Suisse] ; Ortrud Gerstner [Suisse] ; Andreas Weichselberger [Suisse]	The RESTORE Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
002055	Pascale Massin [France] ; Francesco Bandello [Italie] ; Justus G. Garweg [Suisse] ; Lutzl. Hansen [Allemagne] ; Simon P. Harding [Royaume-Uni] ; Michael Larsen [Danemark] ; Paul Mitchell [Australie] ; Dianne Sharp [Nouvelle-Zélande] ; U. E. K. Wolf-Schnurrbusch [Suisse] ; Margarita Gekkieva [Suisse] ; Andreas Weichselberger [Suisse] ; Sebastian Wolf [Suisse]	Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study*): A 12-month, randomized, controlled, double-masked, multicenter phase II study
002641	LEI CHEN [Australie] ; Dianna J. Magliano [Australie] ; Beverley Balkau [Australie] ; Stephen Colagiuri [France] ; Paul Z. Zimmet [Australie] ; Andrew M. Tonkin [Australie] ; Paul Mitchell [Australie] ; Patrick J. Phillips [Australie] ; Jonathan E. Shaw [Australie]	AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024